The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective study of biomarkers in squamous cell carcinoma of the anal canal (SCCAC) and their influence on treatment outcomes: Five-year long-term results.
 
Camila Motta Venchiarutti Moniz
Travel, Accommodations, Expenses - Merck Sharp & Dohme; SERVIER
 
Rachel Pimenta Riechelmann
Honoraria - Amgen; Novartis; Roche/Genentech
Consulting or Advisory Role - Bayer; Roche/Genentech
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Novartis
 
Maria Ignez Braghiroli
No Relationships to Disclose
 
Suilane Coelho Ribeiro
No Relationships to Disclose
 
Thomás Giollo Rivelli
Speakers' Bureau - MSD Oncology
(OPTIONAL) Uncompensated Relationships - Roche
 
Giovanni M. Bariani
Consulting or Advisory Role - Libbs
Research Funding - Bristol-Myers Squibb; Mabxience; Merck Sharp & Dohme
 
Andre Tsin Chih Chen
No Relationships to Disclose
 
Caio Nahas
No Relationships to Disclose
 
Renata Colombo Bonadio
No Relationships to Disclose
 
Cinthia Ortega
Research Funding - GE Healthcare (Inst)
 
Rejane Franco
No Relationships to Disclose
 
Sibele Meireles
No Relationships to Disclose
 
Allan Andresson Lima Pereira
No Relationships to Disclose
 
Jorge Sabbaga
No Relationships to Disclose
 
Renata A. Coudry
No Relationships to Disclose
 
Paulo Marcelo Hoff
Consulting or Advisory Role - Genzyme (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)